Trading Analysis Report: BRK.B
- Analysis date: 2026-05-29
- Processed decision: Overweight
- Price Target: 505.0
I. Analyst Team Reports
Market Analyst
Market Snapshot
- BRK.B closed at $474.48 on 2026-05-29 versus a previous close of $477.42, a 0.62% daily decline.
- Across the displayed recent tape, the stock fell from $486.38 on 2026-05-22 to $474.48 on 2026-05-29, a 2.45% pullback, and 2026-05-29 volume of 7.90 million was the highest volume shown in the provided tail.
- The current price sits 8.20% below the 52-week high of $516.85 and 4.24% above the 52-week low of $455.19.
- The provided snapshot shows a market capitalization of about $1.02 trillion, beta of 0.622, recommendation key of
buy, recommendation mean of 1.75, and analyst targets of $481 low, $510 median, and $520.33 mean.
Read-Through The market setup is defensive rather than momentum-driven. Berkshire is trading well below its 52-week high, but it is not distressed: the low beta, trillion-dollar scale, and narrow analyst target range suggest investors are treating it as a quality compounder with limited near-term downside and modest upside rather than as a high-volatility breakout candidate.
Key Catalysts
- Q1 2026 operating earnings rose to $11.346 billion from $9.641 billion a year earlier.
- Insurance underwriting contributed $1.717 billion and insurance investment income contributed $2.679 billion in Q1 2026.
- Insurance float reached about $176.9 billion at 2026-03-31.
- The supplied snapshot shows cash of $397.38 billion against debt of $128.89 billion, preserving major capital-allocation optionality.
Key Risks
- Berkshire itself says quarterly investment gains and losses can make net earnings per share extremely misleading under GAAP.
- The stock's size limits the probability of very fast growth from here.
- Insurance catastrophe exposure, railroad and utility regulation, and succession and capital-allocation execution remain live risk factors in the provided framing.
- The current price already sits near the supplied low analyst target of $481, which caps the margin of safety if operating momentum slows.
Source-date limitation: Market data comes from the provided yfinance snapshot retrieved at 2026-05-30T05:30:46.234719+00:00, with latest close data dated 2026-05-29. Operating references here come from the Q1 2026 Berkshire release details included in the request context.
Sentiment Analyst
Sentiment Snapshot There is no direct Reddit, StockTwits, or X scrape in the provided materials, so this sentiment view is grounded only in the supplied recommendation data and the tone of the listed Yahoo Finance news records.
Observed Tone
- The provided sell-side backdrop is constructive: recommendation key
buy, recommendation mean 1.75, and target prices above the latest close. - The most clearly bullish supplied headline says higher-for-longer interest rates are turning Berkshire's cash hoard into an earnings engine.
- Another Berkshire-focused opinion piece calls the stock a favorite for 2026 and beyond.
- The main cautionary Berkshire-specific item is the Jim Cramer headline arguing that investors could get bored owning the stock.
- One supplied story is largely unrelated activism conference coverage, and the Occidental headline is only an indirect Berkshire read-through, so not every item in the feed is a clean company-specific signal.
Interpretation Sentiment in the provided dataset is mildly positive, but not euphoric. Berkshire is being framed as a cash-rich defensive compounder that benefits from high rates and disciplined capital allocation, while the main pushback is that a low-drama conglomerate can lag in a momentum market and that the upside case is steadier than explosive.
Source-date limitation: This section uses only the supplied recommendation snapshot and the listed Yahoo Finance news records dated 2026-05-29. It does not claim to be a direct social-media scrape.
News Analyst
Key News Developments From the Provided Snapshot
- A 2026-05-29 Motley Fool item says higher-for-longer interest rates are turning Berkshire Hathaway's cash hoard into an earnings engine.
- A 2026-05-29 24/7 Wall St. item says Berkshire Hathaway is a favorite stock for 2026 and beyond.
- A 2026-05-29 Yahoo Finance-hosted Insider Monkey item highlights Jim Cramer's view that investors may get bored owning Berkshire Hathaway.
- A 2026-05-29 Barron's item on Occidental Petroleum is an indirect Berkshire read-through, not a direct Berkshire operating update.
- A 2026-05-29 CorpGov forum story appears largely unrelated to Berkshire's operating fundamentals.
News Read-Through The provided news flow is supportive, but the quality of the signal is mixed. The Berkshire-specific stories lean positive around cash deployment, resilience, and long-duration attractiveness, while the main negative item is about investor enthusiasm rather than operating deterioration. At the same time, two of the visible stories are not clean Berkshire fundamentals coverage, which lowers the precision of the news signal.
Risk Note The strongest near-term news evidence in the request still comes from the official Q1 2026 release and the linked 10-Q details, not from the commentary headlines. Berkshire's own release warns that the limited press-release information is not adequate for a fully informed investment judgment and points investors to the 10-Q.
Source-date limitation: This section is limited to the supplied Yahoo Finance news records dated 2026-05-29 and the official-source details embedded in the request context.
Fundamentals Analyst
Business Profile Berkshire Hathaway is best treated here as a diversified, cash-rich holding company whose value is driven by insurance operations, investment income, wholly owned operating businesses, public equity exposures, and capital allocation.
Financial Snapshot
- In the provided Q1 2026 release details, net earnings attributable to Berkshire shareholders were $10.106 billion versus $4.603 billion in Q1 2025, while operating earnings were $11.346 billion versus $9.641 billion.
- Berkshire explicitly says investment gains and losses are usually meaningless for judging any single quarter because unrealized equity-security marks flow through GAAP earnings.
- Q1 2026 operating earnings by component were insurance underwriting $1.717 billion, insurance investment income $2.679 billion, BNSF $1.377 billion, Berkshire Hathaway Energy $1.114 billion, manufacturing/service/retailing $3.199 billion, and other $1.260 billion.
- Insurance float was about $176.9 billion at 2026-03-31, up roughly $0.5 billion from year-end 2025.
- The provided 10-Q snippet says Berkshire's diverse businesses generated $10.4 billion of net operating cash flow in Q1 2026, and the filing also notes the OxyChem acquisition closed on 2026-01-02.
- In the supplied market snapshot, trailing revenue is $375.39 billion, revenue growth is 4.4%, earnings growth is 119.6%, operating margin is 14.35%, profit margin is 19.31%, operating cash flow is $45.50 billion, free cash flow is $61.23 billion, cash is $397.38 billion, and debt is $128.89 billion.
Valuation Context The supplied valuation markers are mixed but generally reasonable for a defensive quality conglomerate. BRK.B trades at 14.13x trailing earnings, 22.27x forward earnings, and 2.73x trailing sales. The wide gap between trailing and forward P/E reinforces management's warning that simple earnings optics can be noisy for Berkshire. The balance-sheet picture is stronger: cash exceeds debt by about $268.50 billion in the supplied snapshot. The supplied yfinance book-value fields do not provide a clean per-share valuation anchor, so the cleaner inputs in this dataset are earnings multiples, cash, debt, and the external target range.
Fundamental Conclusion The core fundamental case is solid. Berkshire is not a fast-growth story, but the provided data shows resilient operating earnings, a very large float base, substantial liquidity, and diversified earnings streams. The main valuation question is not whether the business is high quality; it is whether today's price already captures most of that quality given Berkshire's size and the limited upside implied by the supplied analyst targets.
Source-date limitation: This section uses only the official Q1 2026 release details, the linked 10-Q details summarized in the request context, and the supplied yfinance snapshot retrieved at 2026-05-30T05:30:46.234719+00:00.
II. Research Team Decision
Bull Researcher
The bull case for BRK.B is that the provided data shows high-quality earnings with unusually strong balance-sheet flexibility. Q1 2026 operating earnings rose 17.68% year over year to $11.346 billion, insurance underwriting remained profitable at $1.717 billion, insurance investment income was $2.679 billion, and insurance float stood at roughly $176.9 billion. That is a strong base for a company with a beta of just 0.622.
The liquidity profile is a second major advantage. The supplied snapshot shows $397.38 billion of cash versus $128.89 billion of debt, or about $268.50 billion of net cash. In a higher-rate environment, that cash becomes an earnings engine rather than idle ballast, which is exactly the direction of the most bullish supplied Berkshire headline. The 10-Q snippet also says operating businesses generated $10.4 billion of net operating cash flow in Q1 2026, so Berkshire is not relying only on investment marks for its financial strength.
Valuation and market positioning still leave room for a constructive stance. BRK.B closed at $474.48, below the 52-week high of $516.85, while the supplied analyst targets run from $481 to $570 with a $510 median and $520.33 mean. If investors continue rewarding defensive balance sheets, insurance profits, and disciplined capital allocation, Berkshire can re-rate toward the upper half of that target band without requiring a heroic growth assumption.
Bear Researcher
The bear case is that Berkshire's quality is obvious and therefore not especially underappreciated at the current price. The supplied snapshot already shows a $1.02 trillion market capitalization, a buy recommendation key, and target prices above the current quote. When a low-beta conglomerate is already recognized as safe and well-run, upside can compress into mid-single digits rather than a major revaluation.
The second issue is earnings interpretation and growth limits. Berkshire itself warns that quarterly investment gains and losses can make net earnings per share extremely misleading, which means investors must lean on operating earnings and long-run capital allocation instead of headline EPS. That is workable, but it also means the stock can look optically cheap on trailing earnings without actually being a clear bargain. The supplied snapshot also shows only 4.4% revenue growth, which is consistent with a very large mature platform rather than a fast compounding growth stock.
Risk is not absent just because the balance sheet is strong. Insurance catastrophe losses, railroad and utility regulation, execution around major capital allocation decisions, and broader succession uncertainty all matter. The visible tape was also weak into 2026-05-29, with the stock down 2.45% from the 2026-05-22 close and finishing only 1.37% below the supplied low analyst target of $481, which suggests the easy upside may already be reflected in consensus expectations.
Research Manager
Recommendation: Overweight
Rationale: The strongest evidence supports a constructive stance above Hold. The provided Q1 2026 data shows operating earnings growth to $11.346 billion, profitable insurance underwriting, sizable insurance investment income, $176.9 billion of float, and a 10-Q snippet showing $10.4 billion of Q1 operating cash flow. The market snapshot adds $397.38 billion of cash against $128.89 billion of debt, a low 0.622 beta, and analyst targets of $510 median and $520.33 mean versus a $474.48 close.
The recommendation stops short of Buy because the upside implied by the supplied target set is still moderate, Berkshire's scale limits rapid growth, and management itself warns that headline GAAP earnings can be distorted by investment marks. The visible news flow is positive but not overwhelmingly company-specific, and the stock already sits close to the low end of the target range rather than at a distressed entry point.
Strategic Actions: Treat Berkshire as a high-quality, defensive compounding position rather than a deep-value dislocation. Accumulate selectively, prioritize disciplined sizing, and monitor whether operating earnings, float, and cash deployment continue to support a move toward the low-$500s.
III. Trading Team Plan
Trader
Action: Buy
Reasoning: The report stack supports a staged buy rather than an aggressive chase. Berkshire combines resilient operating earnings, very large net cash, and low-beta defensive characteristics, while the supplied analyst targets still sit above the latest close. The opportunity is real, but the expected return profile looks steadier than explosive, so execution discipline matters.
Entry Price: 474.48
Position Sizing: Build exposure gradually rather than treating the current level as a no-risk breakout. The supplied target range implies modest to moderate upside, so Berkshire fits better as a quality accumulation name than as a maximum-conviction momentum trade.
Primary Monitors
- Operating earnings versus the Q1 2026 level of $11.346 billion.
- Insurance underwriting profitability, investment income, and float stability.
- Capital allocation signals from the cash balance and any post-OxyChem integration evidence.
- Whether the stock can recover from the recent late-May pullback without a deterioration in operating data.
FINAL TRANSACTION PROPOSAL: BUY
IV. Risk Management Team Decision
Aggressive Analyst
An aggressive risk mandate can justify leaning long BRK.B here. The provided data shows operating earnings growth, a very large float base, roughly $268.50 billion of net cash, and analyst targets that still point above the $474.48 close. That profile supports upside if the market keeps paying for safety, liquidity, and disciplined capital allocation.
The aggressive case is still not a reason to overtrade a low-beta conglomerate. Berkshire is not a high-velocity earnings story, and the visible target range implies a more measured return path than a breakout setup. The right aggressive posture is overweight with selective adds, not indiscriminate chasing.
Aggressive conclusion: Positive risk/reward for investors willing to accept modest upside in exchange for strong balance-sheet protection and operating resilience.
Conservative Analyst
A conservative risk mandate should stay disciplined. Berkshire's business quality and liquidity are attractive, but the stock is already widely recognized as a defensive winner, and the supplied target range starts only slightly above the latest close. That limits the margin of safety for new capital if operating momentum cools or the market rotates away from defensives.
The balance sheet is a major offset, with cash far above debt, but conservative investors still have to respect insurance catastrophe risk, regulated railroad and utility exposure, and uncertainty around future capital allocation. The recent late-May pullback also shows that even a low-beta name can drift lower when enthusiasm is limited.
Conservative conclusion: Strong business, but best accumulated patiently and with moderate sizing rather than treated as an urgent upside trade.
Neutral Analyst
The neutral risk view supports a constructive but measured stance. Berkshire has enough operating strength, float, and cash optionality to deserve above-benchmark interest, and the supplied target median of $510 implies upside from $474.48. At the same time, the visible upside is not large enough to ignore execution, regulatory, and conglomerate-growth limits.
For a balanced portfolio process, the right interpretation is to stay positive while keeping expectations realistic. If operating earnings and capital deployment continue trending well, the stock can move toward the low-$500s. If growth remains merely steady and not exceptional, Berkshire can still be a sound holding without delivering a major re-rating.
Neutral conclusion: Moderately constructive, with quality and downside resilience offset by limited near-term upside.
V. Portfolio Manager Decision
Portfolio Manager
Rating: Overweight
Executive Summary: BRK.B earns an Overweight rating on 2026-05-29 because the provided data shows resilient operating earnings, profitable insurance operations, very large float, and about $268.50 billion of net cash, all wrapped in a low-beta profile. The stock closed at $474.48, and the supplied analyst target set of $481 low, $510 median, and $520.33 mean supports upside, but not enough to justify a full Buy rating. The position should be accumulated with discipline rather than chased as a high-growth breakout.
Investment Thesis: Berkshire's investment case in this dataset is driven more by operating quality and capital allocation than by headline GAAP earnings. The official Q1 2026 release details show operating earnings of $11.346 billion versus $9.641 billion a year earlier, insurance underwriting profit of $1.717 billion, insurance investment income of $2.679 billion, and float of about $176.9 billion. The linked 10-Q details in the request add $10.4 billion of net operating cash flow in Q1 2026 and note that the OxyChem acquisition closed on 2026-01-02. The market snapshot reinforces that strength with $397.38 billion of cash, $128.89 billion of debt, 14.13x trailing P/E, and a 0.622 beta. That is a high-quality defensive profile.
The reason to stop at Overweight is valuation discipline. The stock is only 8.20% below its 52-week high, only 1.37% below the supplied low analyst target, and the provided news flow is positive but partly commentary-driven rather than purely company-specific. Berkshire itself also warns that quarterly investment gains and losses can distort net earnings, so investors should not overread the headline EPS improvement. The best interpretation is that BRK.B remains a strong core holding candidate, but the return profile from here looks more like steady compounding than dramatic multiple expansion.
Price Target: 505.0
Key Catalysts
- Sustained operating earnings around or above the Q1 2026 level of $11.346 billion.
- Continued profitability in insurance underwriting and insurance investment income.
- Deployment of the company's unusually large cash balance into value-accretive opportunities.
- Evidence that OxyChem integration and the broader operating portfolio continue contributing stable cash generation.
Key Risks
- Berkshire's own warning that quarterly investment marks can distort headline earnings perception.
- Limited growth velocity for a business already above $1 trillion in market value.
- Insurance catastrophe exposure and regulatory sensitivity at BNSF and Berkshire Hathaway Energy.
- Succession and capital-allocation execution risk if investors become less willing to pay for defensive quality.
Valuation Context: The $505.0 price target sits above the current price of $474.48 and above the supplied low analyst target of $481, but below the supplied median target of $510 and mean target of $520.33. That discount to consensus reflects Berkshire's strong balance sheet and earnings resilience, while acknowledging the moderate growth profile and the fact that the supplied book-value fields do not offer a clean per-share anchor for a more aggressive valuation call.
Source-date limitation: This decision uses the provided yfinance snapshot retrieved at 2026-05-30T05:30:46.234719+00:00, with latest close data dated 2026-05-29, plus the official-source details embedded in the request context.